Credit: Getty Images. Lisdexamfetamine dimesylate capsules and chewable tablets are indicated for ADHD in patients aged 6 years and older, and for moderate to severe binge-eating disorder in adults.

Specialty drugs, especially biologics, will constitute a significant portion of global drug spending by 2029, driven by cancer care costs. Autoimmune diseases and multiple sclerosis are key short-term ...

The generic drug market focuses on price. However, multiple generic metformin drugs have been recalled due to poor drug quality. The authors examine price and quality after these recalls. Objectives: ...

The Food and Drug Administration (FDA) has approved Tyruko ® (natalizumab-sztn), a biosimilar to Tysabri (natalizumab). Tyruko is indicated as monotherapy for the treatment of relapsing forms of ...

CivicaScript released a generic version of dalfampridine, a drug used to improve walking in patients with multiple sclerosis, for $16 per bottle of 60 extended-release, 10-milligram tablets. The price ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved multiple first generics of Vyvanse capsules and chewable tablets for ADHD in patients aged ...

With generics of the popular ADHD medication Vyvanse circling the gates, Takeda will have to depend on newer launches to grow going forward. Chief among those is the company’s dengue fever vaccine, ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. The Medical – Generic Drugs industry comprises companies ...